Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study.
about
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentDiagnosis and treatment of diarrhea-predominant irritable bowel syndromeIrritable bowel syndromeIrritable bowel syndrome.Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.Eluxadoline Efficacy in IBS-D Patients Who Report Prior Loperamide Use.Irritable bowel syndrome: a disease still searching for pathogenesis, diagnosis and therapyRecent advances in pharmacological treatment of irritable bowel syndrome.Treatment of irritable bowel syndrome: a review of randomised controlled trials.Irritable bowel syndrome: a clinical reviewThe treatment of irritable bowel syndromeGuidelines on the irritable bowel syndrome: mechanisms and practical management.Pharmacotherapy: non-serotonergic mechanisms.Centrally acting agents and visceral sensitivity.Evaluation of drug treatment in irritable bowel syndrome.Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced DiarrheaAn Evidence-based Approach to Therapy in IBS-D: A Case Study Compendium.New and Emerging Treatment Options for Irritable Bowel Syndrome.Effect of TongXie-YaoFang on Cl(-) and HCO3 (-) Transport in Diarrhea-Predominant Irritable Bowel Syndrome Rats.Updates on treatment of irritable bowel syndrome.Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.Opioids in Gastroenterology: Treating Adverse Effects and Creating Therapeutic Benefits.Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article.Chronic diarrhoea.Eluxadoline in irritable bowel syndrome with diarrhea: rationale, evidence and place in therapy.Pharmacotherapy for Irritable Bowel Syndrome.Advantages and Limitations of the Federal Adverse Events Reporting System in Assessing Adverse Event Reporting for Eluxadoline.Clinical Practice Guidelines for Irritable Bowel Syndrome in Korea, 2017 Revised Edition.Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment
P2860
Q26751193-1E57108A-F5BF-4019-A91B-69B64FE82079Q26765272-CE844E10-0741-422C-9FF7-03D1CDF601A1Q27010213-9B88F997-BFB9-40A5-A644-5B574D0AE45EQ27687723-503D624F-27F8-4E73-AF74-9A6288A14B7DQ33451900-868E5453-DF7D-4D23-93E9-CE03E5B9A985Q33781174-23FC242A-F8B3-4B58-8272-7F752D562954Q33958808-2841D4F2-E5DD-41CA-A3DB-66C3C2D60EDDQ33958853-2C24EDC7-A73D-4821-B475-FB84EE341E42Q34130605-EED1A0EA-27AF-416F-A566-10AC1AF6863EQ34168517-BF64FB9F-0EB4-476D-8271-5C09867AFB6EQ34409009-52ADF12B-6C2B-4F2B-8A25-C9647EC2A816Q34626602-82AA987C-FE1F-46B9-AF37-5DD6EC0C52BEQ34699864-9DDB1963-946F-44E5-B37F-A237A2390380Q34699870-55BF03CE-826A-48A0-9A52-593524ADB538Q35216829-F8F11795-383F-43AE-A110-45FD373277FEQ35840388-89EF97AD-F02F-4E45-8623-55C22786D305Q35917169-1821D7A4-7ABB-4F8F-800E-54980C287BD4Q36180769-850F0BC4-101A-44B6-8B6B-46DDCFFD604FQ37043915-A4358707-B82A-49E0-928B-588985A4BD69Q37156627-60131298-FD4D-48F7-BC82-DCF1CEA8A011Q37632259-BB7F8121-D4F8-4835-9C28-BF71FA03B5AEQ38772298-4375B8F3-EF7A-4703-A778-3D2505511659Q41392745-A8D46DCF-5603-4F0A-9DE7-EAED43EEFF61Q42735880-4E2609ED-1AD8-4F22-A302-AC004608B1CCQ43075643-FFEC836E-86C6-49FB-9BD9-CCCC70955F3DQ47117277-6A4016C7-14F8-47DA-BBC6-D6B163CCAA70Q49860431-1B1F25C3-BF93-4049-8369-38B63E4A4896Q55312184-7CFD7FDC-1E34-4EAA-994D-67AB199621B7Q57300297-3075EC34-C89A-4F75-8C00-9AC5C246869F
P2860
Loperamide in treatment of irritable bowel syndrome--a double-blind placebo controlled study.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Loperamide in treatment of irr ...... lind placebo controlled study.
@ast
Loperamide in treatment of irr ...... lind placebo controlled study.
@en
type
label
Loperamide in treatment of irr ...... lind placebo controlled study.
@ast
Loperamide in treatment of irr ...... lind placebo controlled study.
@en
prefLabel
Loperamide in treatment of irr ...... lind placebo controlled study.
@ast
Loperamide in treatment of irr ...... lind placebo controlled study.
@en
P2093
P1476
Loperamide in treatment of irr ...... lind placebo controlled study.
@en
P2093
P577
1987-01-01T00:00:00Z